Loading organizations...
The Hurvis Group, LLC provides business and consulting services alongside strategic investment activities. The firm advises companies on operational and strategic challenges, leveraging broad industry experience. Their methodology integrates advisory support with capital allocation, fostering growth and enhancing enterprise value across diverse sectors.
Established on March 13, 2013, The Hurvis Group was founded by J. Tom Hurvis, a seasoned entrepreneur with a notable history spanning advertising, chemical manufacturing, and the automotive products industry. His foundational insight centered on applying this extensive, cross-sector expertise to support other businesses through strategic guidance and direct investment. Catherine Wereda serves as the firm's Chief Executive Officer.
The firm’s clients comprise businesses seeking informed strategic direction and capital partners. The Hurvis Group’s long-term vision focuses on cultivating enduring value through thoughtful engagement and disciplined investment in promising enterprises. They aim to contribute to the sustained success of companies they partner with.
The Hurvis Group has 2 tracked investments across 1 company. The latest tracked deal is $30.0M Series C in On Target Laboratories in November 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 16, 2023 | On Target Laboratories | $30.0M Series C | — | 3B Future Health Fund, Elevate Ventures, Gwen Watanabe, Johnson & Johnson Innovation, Nacho Abia, Pension Fund OF The Christian Church |
| Mar 24, 2021 | On Target Laboratories | $21.0M Series B Extension | — | 3B Future Health Fund, Elevate Ventures, H.I.G. Capital, Johnson & Johnson Innovation |